MedPath

Clinical effects of oxytocin prostaglandin anologues versus prostaglandin alone in obstetric patients

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated deliveryHealth Condition 2: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2023/10/058815
Lead Sponsor
B J Government Medical College Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Both primigravida & multigravida

2. Singleton gestation

3. With Cephalic presentation

4. Having indication of vaginal delivery will be included in the study

Exclusion Criteria

1. Cephalopelvic disproportion

2. Multiple pregnancies

3. Placenta previa

4 Previous uterine surgeries

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Comparison of inducing agent or augmenting agent according to age, parity, stage of labour, effacement of cervix <br/ ><br>2. Comparison of Progression of delivery <br/ ><br>3. No. of patients required caesarean section <br/ ><br>4.Comparison of Foetal APGARTimepoint: baseline, 3 hour, 6 hour,9 hour
Secondary Outcome Measures
NameTimeMethod
1. Labour pain <br/ ><br>2. Drug administration & onset of labour time <br/ ><br>3. Dilatation, effacement of cervixTimepoint: baseline <br/ ><br>3 hour <br/ ><br>6 hour <br/ ><br>9 hour
© Copyright 2025. All Rights Reserved by MedPath